DE102005011498A1 - Use of cosmetic preparations containing non-molecularly bound free oxygen - Google Patents

Abstract

Use of cosmetic preparations in the form of O / W emulsions containing from 2.5 to 25% by volume of free oxygen, based on the total volume of the preparation, for increasing skin cell regeneration.

Description

The The present invention relates to the use of cosmetic preparations with a cosmetically effective content of non-molecularly bound free oxygen to increase the skin cell regeneration.

Under Cosmetics can take all measures to summarize the aesthetic establish changes on the skin and hair or for body cleansing. Cosmetics means, therefore, the external appearance too cultivate, improve and beautify, in order to be visible, tangible and smelling way to please fellow human beings as well as oneself. Thousands of years ago, man made cosmetics for this purpose applied. One dyed Lips and face, anointed with precious oils and bathed in fragrant Water.

While the Cleaning effect of a shampoo, the combability improvement of a hair conditioner or the ripple of the hair by a perm simply and objectively detectable are other effects and properties of cosmetic products practically not measurable or only very individually perceptible. For this counting for example, a particular (invigorating, soft, supple, smooth etc.) skin feeling or the softness and smoothness of the skin after the application of a Cosmetics as well as the fullness and Bounce of the hair and the like more.

A for the Consumers very essential, but difficult to quantitative measurable Property of cosmetic products is a particular invigorating and / or smooth skin feel as well as the smoothness of the skin after its application.

task The present invention was to skin care preparations and Preparations for the care of naturally aged skin to disposal The preparations should care for and beautify the body.

It has surprisingly been found and therein lies the solution of these tasks that the
Use of cosmetic preparations in the form of O / W emulsions containing from 2.5 to 25% by volume of free oxygen, based on the total volume of the preparation, for increasing skin cell regeneration
the disadvantages of the prior art helps.

• • der Hauterneuerungseffekt erfrischt,
• • die Hautzellregeneration erhöht und/oder
• • die Hautzellstruktur verjüngt.

The inventive use of the cosmetic preparations with a cosmetically effective content of non-molecularly bound free oxygen -. B. in the form of the examples mentioned - leads in a surprising manner to a significant improvement in the appearance of the skin, in particular by the use of the invention

• • the skin renewal effect refreshes,
• • increases skin cell regeneration and / or
• • rejuvenates the skin cell structure.

Prefers contain the preparations for the purposes of the present invention 5 to 20% by volume, more preferably 7.5 to 15% by volume of free oxygen.

In In this sense, the use according to the invention thus, so to speak the extra breath of pure oxygen for a healthy and rejuvenated skin represents.

Under "Regeneration der Hautzellen "or" skin cell regeneration "is in the sense of Understand that present invention increased the epidermal turnover rate ("epidermal turnover") of the skin becomes. A measure of change the epidermal renewal rate ("turnover rate") is for example the area change the corneocyte ..

The skin cell regeneration can be detected / detected using a fully automated microscope robot system. The method is explained below in a nutshell:
The epidermis of the skin is renewed by the constant re-production of keratinocytes, their differentiation / cornification and desquamation every 28 days. These dander are composed of horny cells essentially consisting of keratin, ie amino acids.

• • Das Messareal wird zuerst einmalig vorgestrippt. Anschließend werden zwei D-Squames auf dieses Areal aufgebracht und nach einmaligem Hin- und Zurückrollen mit dem Gewichtroller von der Hautoberfläche entnommen und auf einen Objektträger mit Barcodes fixiert.
• • Der Objektträger wird dann in die spezielle Roboter-Halterung fixiert. Mit Hilfe von einem Mikroskop wertet der Roboter die Hautabrissproben bildanalytisch aus d.h. die Korneozytenfläche wird bestimmt. Geräte: ZEISS-Mikroskop 200M, Zymark-Roboter und Bildanalyse-Software KS400 Materialien: Objektträger, Barcodes, Gewichtrolle, D-Squames^®

If skin areas (the keratinized skin layer) are replaced with a specific adhesive film (D-squames ^® ), the degree of cell surface change and effects of a treatment can be determined from their measurement. This is done by analyzing the sample breakup using a Durchlichmikroskopes. The individual corneocytes are automatically detected, thereby determining the cell size.

• • The measuring area is first pre-stripped once. Then two D-squames are applied to this area and after a single roll back and forth with the weight roller removed from the skin surface and fixed on a slide with barcodes.
• • The slide is then fixed in the special robot holder. With the aid of a microscope, the robot evaluates the dermal samples by image analysis, ie the corneocyte area is determined. Equipment: ZEISS microscope 200M, Zymark robot and image analysis software KS400 Materials: slides, barcodes, weight roll, D-Squames ^®

It has been surprising proved that the essential basis of the present invention, the pulsed short-term topical application of molecular oxygen. Through a short-term pulse (up to 1 hour) can not be a long-term Resolving a lack of oxygen can be achieved, so that the The present invention differs fundamentally from the prior art. A short-term, pulse- or bolus-like stimulation of the intravenous and extracellular Oxygen content, however, has for the cells of the skin signaling function, as well as different Mechanisms are stimulated, as a result, the cells overall be activated cell physiologically, without causing the disadvantages, associated with long term oxygen use would. A permanent compensation of oxygen deficiency states in the skin should not according to the invention be achieved. However, it is advantageous in the sense of the present Invention, the pulsed application of molecular oxygen regularly - eg. B. 2-3 times daily - to be repeated.

One particular advantage of the present invention is that the molecular Oxygen does not adhere to carrier structures is bound. This has the consequence that a rapid on-and-off of the Gas is possible through the different layers of the skin. Long residence times and the associated risks of oxidative and degenerative processes, which already after a few hours in a strongly oxygen-containing the atmosphere can arise and thereby run contrary to the inventive idea are excluded. The data underlying this invention clearly demonstrate the advantage of a pulsed application with pure against molecular oxygen a permanent supply of oxygen or the application via carrier molecules.

It is particularly advantageous in the context of the present invention, the Oxygen in the form of self-foaming, expanded, foaming or foamable apply cosmetic O / W emulsions to the skin.

Under "self-foaming", "foamy", "nachschäumend" or "foamable" are preparations too understand which foams - be it already during the manufacturing process, be it in the application by the consumer or otherwise - by Entry of one or more gases can be produced in principle. In such foams lie the gas bubbles (arbitrarily) distributed in one (or more) liquid phase (s), wherein the (foamed) Preparations macroscopically not necessarily the appearance have to have a foam. Inventive (foamed) cosmetic Preparations (hereinafter referred to as foams for the sake of simplicity) can z. B. macroscopically visible dispersed systems from in liquids represent dispersed gases. The foam character but can, for example also visible under a (light) microscope. Furthermore are foams according to the invention - in particular then, when the gas bubbles too small to be detected under a light microscope - even on recognizable by the strong volume increase of the system.

• A. mindestens einem Emulgator A, gewählt aus der Gruppe der ganz-, teil- oder nicht neutralisierten, verzweigten und/oder unverzweigten, gesättigten Fettsäuren mit einer Kettenlänge von 10 bis 40 Kohlenstoffatomen,
• B. mindestens einem Emulgator B, gewählt aus der Gruppe der polyethoxylierten Fettsäureester mit einer Kettenlänge von 10 bis 40 Kohlenstoffatomen und mit einem Ethoxylierungsgrad von 5 bis 100 und
• C. mindestens einem Coemulgator C, gewählt aus der Gruppe der gesättigten, verzweigten und/oder unverzweigten Fettalkohole mit einer Kettenlänge von 10 bis 40 Kohlenstoffatomen besteht.

Such preparations may advantageously be in the form of emulsions and advantageously contain an emulsifier system which comprises

• A. at least one emulsifier A selected from the group of fully, partially or not neutralized, branched and / or unbranched, saturated fatty acids having a chain length of 10 to 40 carbon atoms,
• B. at least one emulsifier B, selected from the group of polyethoxylated fatty acid esters having a chain length of 10 to 40 carbon atoms and having a degree of ethoxylation of 5 to 100 and
• C. at least one co-emulsifier C, selected from the group of saturated, branched and / or unbranched fatty alcohols having a chain length of 10 to 40 carbon atoms.

Of the or the emulsifiers A are preferably selected from the group of fatty acids which are completely or partly with usual Alkalis (such as, for example, sodium and / or potassium hydroxide, sodium and / or Potassium carbonate and mono- and / or triethanolamine) neutralized are. For example, stearic acid and are particularly advantageous Stearates, isostearic acid and isostearates, palmitic acid and palmitates as well as myristic acid and myristates.

The emulsifier or emulsifiers B are preferably selected from the following group:
PEG-9 stearate, PEG-8 distearate, PEG-20 stearate, PEG-8 stearate, PEG-25 glyceryl trioleate, PEG-15 glyceryl ricinoleate, PEG-20 glyceryl stearate, PEG-20 glyceryl isostearate, PEG-20 Stearate, PEG-20 methyl glucose sesquistearate, PEG-30 glyceryl isostearate, PEG-20 glyceryl laurate, PEG-30 stearate, PEG-30 glyceryl stearate, PEG-40 stearate, PEG-30 glyceryl laurate, PEG-50 stearate , PEG-100 stearate, PEG-150 laurate. For example, polyethoxylated stearic acid esters are particularly advantageous.

The co-emulsifier (s) C are preferably chosen according to the invention from the following group: behenyl alcohol (C ₂₂ H ₄₅ OH), cetearyl alcohol [a mixture of cetyl alcohol (C ₁₆ H ₃₃ OH) and stearyl alcohol (C ₁₈ H ₃₇ OH)], lanolin alcohols (wool wax alcohols representing the unsaponifiable alcohol fraction of the wool wax obtained after saponification of wool wax). Particularly preferred are cetyl and cetylstearyl alcohol.

It is advantageous in the context of the present invention, the total amount the emulsifiers A and B and the co-emulsifier C from the range of 2 to 10 wt .-%, preferably from 2.5 to 7 wt .-%, each based on the total weight of the formulation to choose.

Further advantageous for the purposes of the present invention are preparations, which are in the form of emulsions and one or more O / W emulsifiers with an HLB value greater than 6. Especially advantageous are the or the O / W emulsifiers from the group of ethoxylated Fatty acids and / or the ethoxylated fatty alcohols chosen. Very particularly advantageous are ceteareth-n, steareth-n, peg-n-stearates and polysorbate, where n values are between 20 and 100 (corresponding to 20 to 100 ethoxy units) can accept.

Further advantageous O / W emulsifiers in the context of the present invention are glyceryl stearate citrate, polyglyceryl-3-methyl glucose distearate and PEG-40 Castor Oil optionally in conjunction with sodium cetearyl sulfate and / or Cetearyl.

Advantageous contain O / W emulsions for the purposes of the present invention in addition one or more O / W emulsifiers further co-emulsifiers selected from the group glyceryl stearate, fatty acids and fatty alcohols. It is particularly advantageous in the context of the present invention, the or the coemulsifiers of the group behenyl alcohol, cetyl alcohol, cetearyl alcohol, To choose stearyl alcohol.

Furthermore, in the context of the present invention, the self-foaming, foam-like, post-foaming or foamable cosmetic emulsions may also contain substances which stabilize the gas-emulsion interface. Such interfacial stabilizers (one or more compounds) may e.g. B. be selected from the group of fillers. The fillers may also z. B. further improve the sensory and cosmetic properties of the formulations and, for example, cause or enhance a velvety or silky feel on the skin. Advantageous fillers for the purposes of the present invention are polymethyl methacrylates, methacrylate copolymers, starch and starch derivatives (such as, for example, tapioca starch, distarch phosphate, aluminum or sodium starch, octenyl succinate and the like), pigments which have neither primary UV filter nor dyeing action have (such as. for example, boron nitride etc.) and / or Aerosils ^® (CAS no. 7631-86-9). Particularly advantageous is talc. Further advantageously, the one or more interface stabilizers from the group of rheological additives can be selected. Aluminum and / or magnesium silicates are particularly advantageous.

Also can be advantageous the emulsions in the context of the present invention also hydrocolloids (also as thickener or gelling agent) containing the preparations can stabilize.

When advantageous according to the invention Hydrocolloids are agar-agar, carrageenan, tragacanth, gum arabic, Alginates, pectins, polyoses, guar flour, locust bean gum, starch, dextrins, Gelatin, casein, cellulose ethers, hydroxyethyl and propyl cellulose derivatives, Polyacrylic and polymethacrylic compounds, vinyl polymers, polycarboxylic acids, polyethers, Polyimines, polyamides, polysilicic acids, clay minerals, zeolites, silicas used.

in der R ein Wasserstoff oder eine Methylgruppe darstellen kann.Hydrocolloids which are preferred according to the invention are: magnesium and / or aluminum silicates and, for example, methylcelluloses, which are referred to as the methyl ethers of cellulose. They are characterized by the following structural formula

in which R can represent a hydrogen or a methyl group.

Especially advantageous in the context of the present invention are in general also referred to as methylcelluloses cellulose mixed ethers, which in addition to a dominating content of methyl additionally 2-hydroxyethyl, 2-hydroxypropyl or 2-hydroxybutyl groups. Especially preferred are (hydroxypropyl) methylcelluloses, for example those under the Trade name Methocel E4M at Dow Chemical Comp. available.

The cosmetic preparations according to the invention can contain cosmetic excipients, such as those commonly used in such preparations be used, for. Preservatives, preservatives, Complexing agents, bactericides, perfumes, substances for increasing of foaming, Dyes, pigments that are a coloring Have effect, thickener, moisturizing and / or moisturizing Substances, fillers, the skin feeling improve, fats, oils, Waxes or other usual Ingredients of a cosmetic formulation such as alcohols, polyols, Polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.

advantageous Preservatives according to the present invention are, for example Iodopropyl butyl carbamates (for example those sold under the trade names Glycacil-L, Glycacil-S available from Lonza and / or Dekaben LMB by Jan Dekker), parabens (i.e., p-hydroxybenzoic acid alkyl esters such as methyl, ethyl, Propyl and / or butylparaben), phenoxyethanol, ethanol, benzoic acid and such more. Usually comprises the preservation system according to the invention also advantageously also preservation aids, such as for example, octoxyglycerol, glycine soy etc.

advantageous Complexing agents in the sense of the present invention are, for example EDTA, [S, S] -ethylenediamine disuccinate (EDDS), which is for example available under the trade name Octaquest from the company Octel, Pentasodium ethylenediamine tetramethylene phosphonate, which z. B. available under the trade name Dequest 2046 from the company Monsanto and / or iminodisuccinic acid, which u. a. from Bayer AG under the trade name Iminodisuccinat VP OC 370 (about 30% solution) and Baypure CX 100 available is.

Especially advantageous preparations are also obtained if, as additional or agents used antioxidants. Included in the invention the preparations advantageously one or more antioxidants. As cheap, but yet optional antioxidants can all be used for cosmetic Applications suitable or common Antioxidants are used.

Especially For the purposes of the present invention, water-soluble antioxidants may be advantageous are used, such as vitamins.

preferred Antioxidants are also vitamin E and its derivatives as well as vitamin A and its derivatives.

The Amount of antioxidants (one or more compounds) in the Preparations is preferably from 0.001 to 30% by weight, particularly preferably from 0.05 to 20 Wt .-%, in particular 0.1 to 10 wt .-%, based on the total weight the preparation.

Provided Vitamin E and / or derivatives thereof are the antioxidant (s), is advantageous, their respective concentrations from the field from 0.001 to 10% by weight, based on the total weight of the formulation, to choose.

Provided Vitamin A or vitamin A derivatives or carotenes or their derivatives the one or more antioxidants are advantageous, their respective Concentrations from the range of 0.001 to 10 wt .-%, based on the total weight of the formulation to choose.

Further advantageous for the purposes of the present invention to be used active ingredients are those that positively affect the condition of the skin, such as In particular, active ingredients for positively influencing the aging skin, the reduce the development of wrinkles or existing wrinkles. Biochinones, in particular ubiquinone, are particularly advantageous (Q10) and ubiquinol, folic acid and their derivatives (especially tetrahydrofolic acid and dihydrofolic acid), niacin and its derivatives (especially niacinamide), creatine and creatinine, Carnitine, biotin, isoflavone, cardiolipin, lipoic acid, anti freezing proteins, Hop and hops malt extracts. Also Agents that promote the restructuring of connective tissue, such as natural and / or synthetic isoflavonoids and isoflavonoid-containing plant extracts - such. B. soy and clover extracts - can in the formulations of the invention to be used very well. It also shows that the formulations are special Way, agents to support the skin functions dry skin (such as vitamin C, biotin, carnitine, propionic acid, Green tea extracts, eucalyptus oil, Urea and mineral salts (such as NaCl, marine minerals) as well as Osmolytes (such as inositol, betaine, quaternary ammonium compounds)) use. In similar Way proved the incorporation of drugs for relief or positive influence of irritative skin conditions, was it is sensitive to sensitive skin in general or irritated by noxious Skin (UV light, chemicals), as beneficial. Here are drugs like sericosides, various extracts of licorice, Licochalcone, in particular licochalcone A, silymarin, silyphos, dexpanthenol, Inhibitors of prostaglandin metabolism, in particular cyclooxygenase and leukotriene metabolism, especially 5-lipoxygenase, but also the 5-lipoxevase inhibitor protein, FLAP. Especially Creatine and creatinine are suitable agents to create a (energy) Create and / or renew depot and repair different cellular Structures, in particular the DNA to activate. Also proved the incorporation of modulators of pigmentation as advantageous. Here are agents that reduce the pigmentation of the skin and so to a cosmetically desired Brighten the skin and / or reduce the occurrence of age spots and / or existing ones Brighten age spots. As an example, mention may be made of tyrosine sulfate, dioic acid (8-hexadecene-1,16-dicarboxylic acid) as well as lipoic acid and liponamide, various extracts of licorice, kojic acid, hydroquinone, Arbutin, alpha-arbutin, Deoxyarbutin, fruit acids, especially alpha hydroxy acids (AHAs), Bearberry (Uvae ursi), ursolic acid, ascorbic acid, green tea extracts, Aminoguanidine, pyridoxamine, niacinamide, inhibitors of proteinase Activated Receptors 2 (PAR-2). Particular preference is furthermore given to formulations according to the invention, which contain further active ingredients that provide an intensified or faster tanning of the Induce skin (Advanced Glycation End Products (AGE), Lipofuscins, Nucleic Acid Oligonucleotides, Purines and pyrimidines, NO-releasing substances), tyrosine and its derivatives (especially N-acetyl-tyrosine), Phenylalanine and its derivatives (especially N-acetyl-phenylalanine), Activators of the Proteinase Activated Receptor 2 (PAR-2), be it with or without the influence of UV light.

Inventive formulations, which z. B. known anti-wrinkling agents such as flavone glycosides (especially α-glycosyl rutin), Coenzyme Q10, vitamin E and / or derivatives and the like, are particularly advantageous for prophylaxis and treatment cosmetic or dermatological lesions, such as. B. at Skin aging (such as dryness, roughness and training of dryness wrinkles, Itching, reduced refatting (eg after washing), visible vascular dilations (telangiectasias, Cuperosis), slackness and development of wrinkles and wrinkles, local hyper-, hypo- and false pigmentations (eg age spots), increased susceptibility across from mechanical stress (eg cracking) and the like). Farther Advantageously, they are suitable against the appearance of dry or rough skin.

When Moisturizers are substances or mixtures of substances, which give cosmetic properties the property after application or distributing on the skin surface the moisture release of the Horn layer (also called transepidermal water loss (TEWL)) to reduce and / or to positively influence the hydration of the horny layer. Advantageous moisturizers in the context of the present invention are for example, glycerin, lactic acid and / or lactates, in particular sodium lactate, butylene glycol, propylene glycol, biosaccharides Gum-1, glycine soy, ethylhexyloxyglycerol, pyrrolidonecarboxylic acid and Urea.

The oil phase of Preparations in the context of the present invention contains advantageous contain nonpolar, for example, those which are chosen from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, Vaseline (petrolatum), paraffin oil, squalane, Polyolefins, hydrogenated polyisobutenes and isohexadecane. Under Polydefins are the preferred substances for polyolefins.

It is particularly advantageous in the context of the present invention, if the content of polar oils with a polarity of less than 20 mN / m (interfacial tension against water) less than 5 wt .-% - based on the total weight the preparation - is chosen.

Advantageous can the oil phase also have a content of cyclic or linear silicone oils or Completely from such oils although it is preferred, except the silicone oil or silicone oils additional Content of other oil phase components to use.

werden auch als Polydimethylsiloxan bzw. Dimethicon (INCI) bezeichnet. Dimethicone gibt es in verschiedenen Kettenlängen bzw. mit verschiedenen Molekulargewichten.Silicone oils are synthetic compounds in which silicon atoms via oxygen atoms chain and / or net-like linked and the remaining valences of silicon by hydrocarbon radicals (usually methyl, more rarely ethyl, propyl, phenyl groups, etc.) are saturated , Systematically, the silicone oils are called polyorganosiloxanes. The methyl-substituted polyorganosiloxanes, which are the quantitatively most important compounds of this group and are characterized by the following structural formula

are also referred to as polydimethylsiloxane or dimethicone (INCI). Dimethicones are available in different chain lengths or with different molecular weights.

According to the invention advantageous is to use cyclomethicone (octamethylcyclotetrasiloxane) as a silicone oil. But also other silicone oils are advantageous for the purposes of the present invention to use for example, hexamethylcyclotrisiloxane, polydimethylsiloxane, poly (methylphenylsiloxane).

Especially advantageous polyorganosiloxanes in the context of the present invention are, for example, dimethylpolysiloxanes (poly (dimethylsiloxane)], which, for example, under the trade names Abil 10 bis 10,000 available from Th. Goldschmidt are. Also advantageous are phenylmethylpolysiloxanes (INCI: phenyl dimethicone, Phenyl trimethicone), cyclic silicones (octamethylcyclotetrasiloxane or decamethylcyclopentasiloxane), which according to INCI also called cyclomethicones amino-modified silicones (INCI: amodimethicone) and silicone waxes, e.g. B. Polysiloxane-polyalkylene copolymers (INCI: Stearyl dimethicones and cetyl dimethicones) and dialkoxydimethylpolysiloxanes (Stearoxy dimethicone and behenoxy stearyl dimethicone) which as different Abil wax types are available from Th. Goldschmidt. But also other silicone oils are advantageous for the purposes of the present invention to use for example, cetyl dimethicone, hexamethylcyclotrisiloxane, polydimethylsiloxane, Poly (methylphenylsiloxane).

• (a) Siloxanelastomere, welche die Einheiten R₂SiO und RSiO_1,5 und/oder R₃SiO_0,5 und/oder SiO₂ enthalten, wobei die einzelnen Reste R jeweils unabhängig voneinander Wasserstoff, C_1-24-Alkyl (wie beispielsweise Methyl, Ethyl, Propyl) oder Aryl (wie beispielsweise Phenyl oder Tolyl), Alkenyl (wie beispielsweise Vinyl) bedeuten und das Gewichtsverhältnis der Einheiten R₂SiO zu RSiO_1,5 aus dem Bereich von 1 : 1 bis 30 : 1 gewählt wird;
• (b) Siloxanelastomere, welche in Silikonöl unlöslich und quellfähig sind, die durch die Additionsreaktion eines Organopolysiloxans (1 ), das siliciumbebundenen Wasserstoff enthält, mit einem Organopolysiloxan (2), das ungesättigte aliphatische Gruppen enthält, erhältlich sind, wobei die verwendeten Mengenateile so gewählt werden, daß die Menge des Wasserstoffes des Organopolysiloxans (1) oder der ungesättigten aliphatischen Gruppen des Organopolysiloxans (2) • im Bereich von 1 bis 20 mol-% liegt, wenn das Organopolysiloxan nicht cyclisch ist und • im Bereich von 1 bis 50 mol-% liegt, wenn das Organopolysiloxan cyclisch ist.

The preparations according to the present invention may also advantageously contain one or more substances from the following group of siloxane elastomers, for example in order to increase the water resistance and / or the sun protection factor of the products:

• (A) siloxane elastomers containing the units R ₂ SiO and RSiO _1.5 and / or R ₃ SiO _0.5 and / or SiO ₂ , wherein the individual radicals R are each independently hydrogen, C _1-24 alkyl (as for example, methyl, ethyl, propyl) or aryl (such as phenyl or tolyl), alkenyl (such as vinyl) and the weight ratio of the units R ₂ SiO to RSiO _{1.5 is selected} from the range of 1: 1 to 30: 1 ;
• (b) Siloxane elastomers which are insoluble and swellable in silicone oil obtainable by the addition reaction of an organopolysiloxane (1) containing silicon-bonded hydrogen with an organopolysiloxane (2) containing unsaturated aliphatic groups, the proportions used being such in that the amount of hydrogen of the organopolysiloxane (1) or of the unsaturated aliphatic groups of the organopolysiloxane (2) is in the range from 1 to 20 mol%, if the organopolysiloxane is not cyclic, and in the range from 1 to 50 mol% % is when the organopolysiloxane is cyclic.

Advantageous For the purposes of the present invention, the siloxane elastomer (s) are present in the form of spherical Powder or in the form of gels.

According to the invention advantageous in the form of spherical Powder present siloxane elastomers are those with the INCI name Dimethicone / Vinyl Dimethicone Crosspolymer, for example that of DOW CORNING under the trade designations DOW CORNING 9506 Powder available.

Especially it is preferred if the siloxane elastomer in combination with oils Hydrocarbons of animal and / or vegetable origin, synthetic oils, synthetic Esters, synthetic ethers or mixtures thereof is used.

All it is particularly preferred if the siloxane elastomer in combination with unbranched at room temperature liquid or pasty silicone oils or cyclic silicone oils or mixtures thereof is used. Particularly advantageous Organopolysiloxane elastomers with the INCI name Dimethicone / Polysilicone-11, especially those available from Grant Industries Inc. Gransil types GCM, GCM-5, DMG-6, CSE gel, PM gel, LTX, ININ gel, AM-18 Gel and / or DMCM-5.

All exceptionally preferred it is when the siloxane elastomer is in the form of a gel of siloxane elastomer and a lipid phase, wherein the content of the siloxane elastomer in which gel is 1 to 80% by weight, preferably 0.1 to 60% by weight, respectively based on the total weight of the gel.

It is advantageous in the context of the present invention, the total amount the siloxane elastomers (active content) from the range of 0.01 to 10 wt .-%, advantageously from 0.1 to 5 wt .-%, each based on the total weight of the formulation to choose.

It is also advantageous in the context of the present invention, cosmetic Preparing preparations whose main purpose is not protection is sunlight, but still contains a content of other UV-protective substances contain. So z. In day creams or make-up products usually Incorporated UV-A or UV-B filter substances. Also, UV protectors, as well as antioxidants and, if desired, preservatives, effective protection of the preparations themselves against spoilage. Cheap are also cosmetic preparations in the form of a sunscreen available.

Accordingly contain the preparations for the purposes of the present invention preferably at least one further UV-A, UV-B and / or broadband filter substance. The formulations can, although not necessary, optionally also one or more organic and / or inorganic pigments as UV filter substances, which may be present in the water and / or the oil phase.

The Preparations according to the present invention Invention can furthermore advantageously also in the form of so-called oil-free cosmetic emulsions which are a water phase and at least one at room temperature liquid UV filter substance as a further phase and which in particular can also be advantageous free of other oil components.

Particularly advantageous UV filter substances which are liquid at room temperature in the context of the present invention are homomenthylsalicylate (INCI: homosalates), 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (INCI: octocrylene), 2-ethylhexyl-2-hydroxybenzoate (2 Ethylhexyl salicylate, octyl salicylate, INCI: ethylhexyl salicylate) and esters of cinnamic acid, preferably 4-methoxycinnamic acid (2-ethylhexyl) ester (2-ethylhexyl-4-methoxycinnamate, INCI: ethylhexyl methoxycinnamate) and isopentyl 4-methoxycinnamate (isopentyl-4-methoxycinnamate, INCI : isoamyl p-Methoxycinnamate), 3- (4- (2,2-bis ethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxan / dimethylsiloxane - copolymer which is obtainable for example from Hoffmann La Roche under the trade name Parsol ^® SLX.

Preferred inorganic pigments are metal oxides and / or other water-insoluble or insoluble metal compounds, in particular oxides of titanium (TiO ₂ ), zinc (ZnO), iron (eg Fe ₂ O ₃ ), zirconium (ZrO ₂ ), silicon ( SiO ₂ ), manganese (for example MnO), aluminum (Al ₂ O ₃ ), cerium (for example Ce ₂ O ₃ ), mixed oxides of the corresponding metals and mixtures of such oxides and also the barium sulfate (BaSO ₄ ).

The Pigments can advantageous in the context of the present invention also in the form of a commercial available oily or aqueous predispersions come into use. These predispersions may advantageously dispersants and / or solubilization promoters may be added.

The Pigments can According to the invention advantageous superficial be treated ("coated"), for example a hydrophilic, amphiphilic or hydrophobic character formed should be or should be preserved. This surface treatment can consist of that the Pigments according to known methods with a thin hydrophilic and / or hydrophobic inorganic and / or organic layer be provided. The different surface coatings can be used in the According to the present invention also contain water.

Suitable titanium dioxide particles and predispersions of titanium dioxide particles are available from the following companies under the following trade names:

Advantageous UV-A filter substances for the purposes of the present invention are dibenzoylmethane derivatives, in particular 4- (tert-butyl) -4'-methoxydibenzoylmethane (CAS-Nr. 70356-09-1), marketed by Givaudan under the trade name Parsol ^® 1789 and is sold by Merck under the trade name Eusolex ^® 9020th

• • Phenylen-1,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonsäure und ihre Salze, besonders die entsprechenden Natrium-, Kalium- oder Triethanolammonium-Salze, insbesondere das Phenylen-1,4-bis-(2-benzimidazyl)-3,3'-5,5'-tetrasulfonsäure-bis-natriumsalz mit der INCI-Bezeichnung Disodium Phenyl Dibenzimidazol Tetrasulfonat (CAS-Nr.: 180898-37-7), welches beispielsweise unter der Handelsbezeichnung Neo Heliopan AP bei Symrise erhältlich ist;
• • Salze der 2-Phenylbenzimidazol-5-sulfonsäure, wie ihr Natrium-, Kalium- oder ihr Triethanolammonium-Salz sowie die Sulfonsäure selbst mit der INCI Bezeichnung Phenylbenzimidazole Sulfonsäure (CAS.-Nr. 27503-81-7), welches beispielsweise unter der Handelsbezeichnung Eusolex 232 bei Merck oder unter Neo Heliopan Hydro bei Symrise erhältlich ist;
• • 1,4-di(2-oxo-10-Sulfo-3-bornylidenmethyl)-Benzol (auch: 3,3'-(1,4-Phenylendimethylene)-bis-(7,7-dimethyl-2-oxo-bicyclo-[2.2.1]hept-1-ylmethan Sulfonsäure) und dessen Salze (besonders die entprechenden 10-Sulfato-verbindungen, insbesondere das entsprechende Natrium-, Kalium- oder Triethanolammonium-Salz), das auch als Benzol-1,4-di(2-oxo-3-bornylidenmethyl-10-sulfonsäure) bezeichnet wird. Benzol-1,4-di(2-oxo-3-bornylidenmethyl-10-sulfonsäure) hat die INCI-Bezeichnung Terephtalidene Dicampher Sulfonsäure (CAS.-Nr.: 90457-82-2) und ist beispielsweise unter dem Handelsnamen Mexoryl SX von der Fa. Chimex erhältlich;
• • Sulfonsäure-Derivate des 3-Benzylidencamphers, wie z. B. 4-(2-Oxo-3-bornylidenmethyl)benzolsulfonsäure, 2-Methyl-5-(2-oxo-3-bornylidenmethyl)sulfonsäure und deren Salze.
• • Benzoxazol-Derivate, wie z. B. das 2,4-bis-[5-1(dimethylpropyl)benzoxazol-2-yl-(4-phenyl)-imino]-6-(2-ethylhexyl)-imino-1,3,5-triazin mit der CAS Nr. 288254-16-0, welches bei 3V Sigma unter der Handelsbezeichnung Uvasorb^® K2A erhältlich ist.
• • Hydroxybenzophenone, z. B. der 2-(4-Diethylamino-2-hydoxybenzoyl)-benzoesäurehexylester (auch: Aminobenzophenon), welcher unter der Handelsbezeichnung Uvinul A Plus bei der Fa. BASF erhältlich ist.
• • Triazinderivate, wie z. B. 2,4-Bis-{[4-(2-Ethyl-hexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-1,3,5-triazin (INCI: Bis-Ethylhexyloxylphenol Methoxyphenyl Triazin), welches unter der Handelsbezeichnung Tinosorb^® S bei der CIBA-Chemikalien GmbH erhältlich ist; Dioctylbutylamidotriazon (INCI: Diethylhexyl Butamido Triazone), welches unter der Handelsbezeichnung UVASORB HEB bei Sigma 3V erhältlich ist; 4,4',4'-(1,3,5-Triazin-2,4,6-triyltriimino)-tris-benzoësäure-tris(2-ethylhexylester), auch: 2,4,6-Tris-[anilino-(p-carbo-2-ethyl-1-hexyloxy)]-1,3,5-triazin (INCI: Ethylhexyl Triazone), welches von der BASF Aktiengesellschaft unter der Warenbezeichnung UVINUL^® T 150 vertrieben wird; 2-[4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-(octyloxy)phenol (CAS Nr.: 2725-22-6).
• • Benzotriazole, wie z. B. 2,2'-Methylen-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)-phenol) (INCI: Methylene Bis-Benztriazolyl Tetramethylbutylphenol), welches z. B. unter der Handelsbezeichnung Tinosorb^® M bei der CIBA-Chemikalien GmbH erhältlich ist.
• • 3-Benzylidencampher-Derivate, vorzugsweise 3-(4-Methylbenzyliden)campher, 3-Benzylidencampher;
• • 4-Aminobenzoesäure-Derivate, vorzugsweise 4-(Dimethylamino)-benzoesäure(2-ethylhexyl)ester, 4-(Dimethylamino)benzoesäureamylester;
• • Ester der Benzalmalonsäure, vorzugsweise 4-Methoxybenzalmalonsäuredi(2-ethylhexyl)ester;
• • Ester der Zimtsäure, vorzugsweise 4-Methoxyzimtsäure(2-ethylhexyl)ester, 4-Methoxyzimtsäureisopentylester;
• • Derivate des Benzophenons, vorzugsweise 2-Hydroxy-4-methoxybenzophenon, 2-Hydroxy-4-methoxy-4-methylbenzophenon, 2,2-Dihydroxy-4-methoxybenzophenon sowie
• • an Polymere gebundene UV-Filter
• • Ethylhexyl-2-cyano-3,3-diphenylacrylat (Octocrylen), welches von BASF unter der Bezeichnung Uvinul^® N 539 T erhältlich ist.

Advantageous UV filter substances in the context of the present invention are also:

• Phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid and its salts, especially the corresponding sodium, potassium or triethanolammonium salts, especially the phenylene-1,4 bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid bis-sodium salt with the INCI name Disodium Phenyl Dibenzimidazole tetrasulfonate (CAS No .: 180898-37-7), which is available, for example, under the Trade name Neo Heliopan AP available at Symrise;
• Salts of 2-phenylbenzimidazole-5-sulfonic acid, such as its sodium, potassium or triethanolammonium salt, and the sulfonic acid itself with the INCI name phenylbenzimidazole sulfonic acid (CAS No. 27503-81-7), which is available, for example, from Trade name Eusolex 232 available from Merck or Neo Heliopan Hydro from Symrise;
• 1,4-di (2-oxo-10-sulfo-3-bornylidenemethyl) benzene (also: 3,3 '- (1,4-phenylenedimethylene) -bis (7,7-dimethyl-2-oxo) bicyclo [2.2.1] hept-1-ylmethane sulfonic acid) and its salts (especially the corresponding 10-sulfato compounds, in particular the corresponding sodium, potassium or triethanolammonium salt), also known as benzene-1,4 benzene-1,4-di (2-oxo-3-bomylidenemethyl-10-sulfonic acid) has the INCI name Terephtalidene Dicampher sulfonic acid (CAS.No. : 90457-82-2) and is available, for example, under the trade name Mexoryl SX from Chimex;
• Sulfonic acid derivatives of 3-Benzylidencamphers, such as. B. 4- (2-oxo-3-bomylidenemethyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bomylidenemethyl) sulfonic acid and salts thereof.
• Benzoxazole derivatives, such as. B. the 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine with the , which is available from 3V Sigma under the trade name Uvasorb K2A ^® CAS no. 288254-16-0.
• Hydroxybenzophenones, e.g. B. 2- (4-diethylamino-2-hydroxybenzoyl) -benzoesäurehexylester (also: aminobenzophenone), which is available under the trade name Uvinul A Plus in the company. BASF.
• Triazine derivatives, such as. For example, 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine (INCI: bis-ethylhexyloxy-phenol methoxyphenyl , which is available under the trade name Tinosorb ^® S from CIBA-Chemikalien GmbH triazine); Dioctylbutylamidotriazone (INCI: Diethylhexyl Butamido Triazone), which is available under the trade name UVASORB HEB from Sigma 3V; 4,4 ', 4' - (1,3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester), also: 2,4,6-tris [anilino- (p-carbo-2-ethyl-1-hexyloxy)] - 1,3,5-triazine (INCI: ethylhexyl Triazone), which is sold by BASF Aktiengesellschaft under the trade name UVINUL T 150 ^®; 2- [4,6-bis (2,4-dimethylphenyl) -1,3,5-triazin-2-yl] -5- (octyloxy) phenol (CAS No .: 2725-22-6).
• Benzotriazoles, such as. B. 2,2'-methylene-bis- (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol) (INCI: Methylene bis-benztriazolyl tetramethylbutylphenol), which z. B. under the trade name Tinosorb ^® M is available from CIBA-Chemikalien GmbH.
• 3-benzylidene camphor derivatives, preferably 3- (4-methylbenzylidene) camphor, 3-benzylidene camphor;
• 4-aminobenzoic acid derivatives, preferably 2-ethylhexyl 4- (dimethylamino) benzoate, 4- (dimethylamino) benzoic acid amyl ester;
• Esters of benzalmalonic acid, preferably di-2-ethylhexyl 4-methoxybenzalmalonate;
• Esters of cinnamic acid, preferably 4-methoxycinnamic acid (2-ethylhexyl) ester, 4-methoxycinnamic acid isopentyl ester;
• Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4-methylbenzophenone, 2,2-dihydroxy-4-methoxybenzophenone and
• • polymer-bound UV filters
• • ethylhexyl-2-cyano-3,3-diphenylacrylate (octocrylene), which is available from BASF under the name Uvinul N 539 T ^® available.

Especially advantageous preparations according to the present invention, which are characterized by a high or very high UV-A protection, contain in addition to the filter substance (s) according to the invention or preferred further UV-A and / or broadband filters, in particular Dibenzoylmethanderivate [for example 4- (tert-butyl) -4'-methoxydibenzoylmethane] and / or the 2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine and / or phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid bis-sodium salt each individually or in any combination with each other.

The List of said UV filters, for the purposes of the present invention can be used Of course not limiting.

The Total amount of filter substances is from the range of 0.1 to 30 wt .-%, preferably 0.5 to 10 wt .-%, in particular 1.0 to 6.0% by weight, based in each case on the total weight of the preparations, of to provide cosmetic preparations containing the hair or the skin in front of the entire range of ultraviolet radiation protect.

It is particularly advantageous in the context of the present invention, the To provide preparations containing oxygen in packaging materials, which ensure a minimum gas exchange.

such Packaging are z. B. from the two-chamber technology known. Advantageous For example, the so-called. Bag-on-valve systems consisting of a valve that is hermetically sealed with a foil bag is. The foil bag is optimally multi-layered with at least one or more barrier layers. The bag valve is in front of the filling hermetically sealed with an aerosol container (aluminum, tinplate or Plastic).

At the So-called bag-in-can system, the bag is in an aerosol container and will when closing connected to the valve and the aerosol container.

described are such packaging in DE-20301831, EP-972923, EP-1061006 or EP-586295, which are hereby incorporated herein by reference Invention be included.

Of the container is preferred with environmentally friendly propellants, such as nitrogen or noble gases, applied, with the propellant gas between the bag and sealed aerosol container whereas the cosmetic is in the pouch.

The Functioning of bag-in-can systems or bag-on-valve systems let yourself describe as follows: the propellant surrounds the with the cosmetic filled Bag. If the nozzle, the spray or application head of the system is depressed, the pressure causes the bag for that, that the content, depending on the diameter of the nozzle, in different quantities exit. For this purpose, the preparation in the bag must be on the Packaging to be matched with respect to the viscosity of the right To achieve application at a given can pressure.

advantage two-chamber technology (bag-in-can systems, bag-on-valve systems) is that no pollution and therefore no air in the under pressure standing bag can penetrate.

Of the Dispensing head optimally contains a at the outlet opening Closing mechanism, the one possible Contamination of the product between the valve opening and the outlet opening is reduced.

The self-closing dispensing head can z. By operating the applicator, an aerosol valve is opened, the product flows through a channel to the outlet opening. As it flows through the channel, the elastic element (for example, made of a thermoplastic elastomer (TPE), polyethylene, polypropylene, polyoxymethylene (POM)), which expands the channel to the outlet port keeps closed in the unsolved state. Prerequisite for this is a higher dose pressure in relation to the ambient atmosphere.

At the Closing the aerosol valve will reduce the pressure between the aerosol valve and outlet reduced to complete sealing. By lowering the pressure decreases The elastic element in the product-carrying channel, and the remaining filling will until the complete Closing the canal applied.

On This way, a contamination of the remaining contents in the dispensing head through the ambient atmosphere until the next opening of the Aerosol valve prevents.

Of the self-closing dispensing head can also z. B. be carried out as follows:

By activity The applicator opens an aerosol valve, an elastic membrane springs opposite to the product flow. Inseparable with the Diaphragm connected plug follows this movement, and the outlet / Ringschlitzdüse is open.

At the Close the aerosol valve leaves the product stream after. The pressure drop causes membrane to move and plug in its initial position and the outlet / Ringschlitzdüse is closed.

Also By this principle, the contents optimally protected in the head.

The The following examples are intended to illustrate the present invention, without restricting it. The Numerical values in the examples mean percentages by weight on the total weight of the respective preparations.

1 Self-foaming, foamy O / W lotions and creams

3 (schäumbare O/W-Creme)

4 (schäumbareO/W-Lotion):

5 (schäumbare Sonnenschutz-Cremes):

• Zur Herstellung des Schaums werden 85 Vol.-% der Emulsion 12, 13 mit Sauerstoff aufgeschäumt^a.

6 O/W Emulsionen

7 Schäume

• Zur Herstellung des Schaums werden 80–97 Vol.-% der Emulsion I mit 3–20 Vol.-% eines geigneten Gases (z.B. Propan/Butan, Druckluft, Stickstoff) aufgeschäumt.

Predispersion of the inorganic gelling agent and swelling of the hydrocolloid with stirring in the water phase. Combination of the heated to 75 ° C fatty phase with the heated to 70 ° C water phase. Addition of the particulate hydrophobic, hydrophobized solid substances with stirring. Homogenization by means of a Zahnkranzdispergiermaschine (rotor-stator principle) at 65 ° C. 45 min stirring under vacuum and cooling. Add the additives at 30 ° C (perfume, active ingredients). Homogenization by means of a Zahnkranzdispergiermaschine (rotor-stator principle) at 27 ° C. Fumigation of the emulsion at 7-8 bar by means of a dynamic foam generator (eg from HANSA INDUSTRIE MIXER) with oxygen. 2 (foamable O / W emulsion make-up):

3 (foamable O / W cream)

4 (foamable O / W lotion):

5 (foamable sunscreen creams):

• To produce the foam, 85% by volume of the emulsion 12, 13 are foamed with oxygen ^a .

6 O / W emulsions

7 foams

• To produce the foam, 80-97% by volume of emulsion I is foamed with 3-20% by volume of a suitable gas (eg propane / butane, compressed air, nitrogen).

Claims (5)

Use of cosmetic preparations in Form of O / W emulsions containing 2.5 to 25% by volume of free oxygen on the total volume of preparation - to increase the Skin cell regeneration. Use according to claim 1, characterized that the Oxygen content - related on the total volume of the preparation - from the range of 5 to 20 vol.% Selected becomes. Use according to one of the preceding claims, characterized characterized in that Oxygen content - related on the total volume of the preparation - from the range of 7.5 to 15 vol.% Is selected. Use according to one of the preceding claims Refreshment of the skin renewal effect. Use according to one of the preceding claims rejuvenation the skin cell structure.